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ABSTRACT 
The ability of atomic layer deposited (ALD) metal oxide films to serve as protective, 
encapsulating barriers for biological implants is determined through testing the corrosion 
resistance and degradation behavior of the films. Using plasma enhanced ALD (PE-ALD), metal-
oxides are deposited at 100 oC onto gold electrodes. Through MTT cell proliferation assay, the 
films are determined to be cytologically compatible and will not cause harm to the implant host. 
Using electrochemical impedance spectroscopy (EIS), the films establish their relative chemical 
stabilities within three different biological environments, phosphate buffer solution (PBS), 
simulated sweat and simulated saliva. The resulting data from the EIS measurements 
demonstrates the rate of degradation for the four respective films and exhibits which films are 
best suited as protective barriers for biological implants. ALD Al2O3 is not suitable as an 
encapsulating layer as it demonstrates no corrosion resistance. Within PBS, ALD TiO2 
establishes itself as the most stable film barrier while within simulated sweat and saliva ALD 
ZrO2 is the most chemically stable. The viability of ALD films in biological solutions and their 
enhanced corrosion resistances opens up the possibility for a new class of materials that can be 
used for the protection of bioimplants and wearable devices.  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INTRODUCTION 
Through the development of flexible, slimmer biological sensors, researchers aim to 
create wearable and implantable devices with the capability of diagnosing diseases or health 
issues in a more efficient, timely manner [1]. The improved monitoring capabilities and ease of 
use of the improved medical devices have resulted in thinner sensors becoming commonplace in 
the medical market. These devices can range from neural implants to cochlear implants, drug-
eluting stents, pacemakers, heart valves and other physiological monitors [2-6]. The biological 
environments these devices are subjected to can cause degradation or corrosion of the device, 
prompting the need for a protective barrier.  
In order to enable small form factor implantable sensors for biomarker detection, human 
performance monitoring, and treating diseases, the devices must be either inherently 
biocompatible or have coatings that prevent the electronics from degrading without negatively 
affecting the host. Currently, the most common method used for electronic protection is a 
hermetically packaged, laser-welded enclosure. The limited range of motion from the hermetic 
packaging inhibits the flexibility of newer medical devices as they conform to the human body 
[7], prompting the need for newer methods of device protection. The barrier films for biological 
implants must allow for nominal device operation while providing protection from corrosion 
without adversely affecting the surrounding cells. It is important for the films to be 
biocompatible or cytocompatible as they cannot negatively affect their surrounding environments 
and must ensure safe, long-term operation within the human body [8]. 
If a medical implant is to be protected from degradation and electrical failure, the barrier 
coatings must be able to withstand harsh biological environments. Effective barrier coatings are 
chemically and mechanically stable, biologically compatibly (also known as cytocompatibility), 
and exhibit low permeability to environmental stressors that could lead to the corrosion or 
degradation of the devices [9]. 
High density inorganic barrier coatings, such as metal oxides, prove to be a viable choice 
as they exhibit excellent gas diffusion barrier properties and ultralow water vapor transmission 
rates when deposited using atomic layer deposition (ALD) [10]. Other materials (e.g. Teflon, 
parylenes, diamond-like carbon (DLC) and silicones) have been explored as potential barrier 
coatings [11-13]. Polymers, although known to be USP Class VI biocompatibility materials with 
low dielectric constants and high electrical resistance, exhibit high diffusion coefficients, thus 
rendering them ineffective in biological solutions when compared to inorganics [14]. Of the 
multiple materials used to establish a biocompatible protective barrier for medical devices, metal 
oxides, if cytocompatible, will allow for higher corrosion resistances within the films due to their 
low water vapor transmission rates.  
The research gathered by Helmus et. al. suggests that biocompatibility can be forced on 
devices through synthetics, passive and bioactive coatings, and nanomaterials [15]. Many 
materials have already proven biocompatible behavior, such as Zr and Ti, as shown in research 
conducted by Izquierdo et al. [16]. Beyond coating the device, researchers have developed 
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biocompatibility through surface modification. In Micksch et al.’s study regarding the surface 
modification of implants, he utilizes specific surface binding peptides in order to determine an 
adsorption level that proved stable in a biological environment [17]. The peptide sequences 
adsorbed on ZrO2, TiZr, and TiO2 coated sensor chips demonstrated that under stress, the sensors 
could still function while maintaining biocompatibility, the effects seen through the adhesion and 
propagation of human mesenchymal stem cells. Not every peptide proved to have a high, stable 
adsorption level, but those that maintained a high adsorption level demonstrated surface 
modification as an adequate method to ensure biocompatibility is an intrinsic property of the 
medical device.  
Although surface layer and surface modification prove to be sufficient methods to 
establish biocompatibility, neither can account for a thin flexible piece of technology that would 
require biocompatibility to be established on the nanoscale level. As Xie et al. [7] discovered in 
his experiment to determine an encapsulation method that refrained from interfering with the 
functionality of a device’s electrical components, plasma atomic layer deposition (PE-ALD) 
serves as a new, yet high performing method to establish biocompatibility. PE-ALD is a well-
established method of layer-by-layer deposition for protective barriers on polymers, ceramics 
and other materials. Within Xie et al.’s experiment, the encapsulation underwent electrochemical 
impedance spectroscopy to determine the corrosion resistance, electrical impedance, current 
leakage, and barrier properties of the film. These variables proved Al2O3 and Parylene C layers’ 
effectiveness as encapsulation materials. Xie et al.’s study was conducted over a 24-hour time 
period. As the films’ purpose is to allow long term use of medical devices additional studies to 
measure corrosion rates must be done over a longer duration. 
Within this study, each metal-oxide coating’s respective cytocompatibility and 
degradation behavior is established. Using MTT cell proliferation assay, the viability of the 
coatings within the human body is established. In order for the films to be considered as potential 
corrosion barriers, they must not adversely affect the surrounding cells while implanted. All four 
metal oxides proved to be non-toxic and did not interfere with their surrounding biological 
environments. Beyond cell compatibility, the corrosion resistance of each film is necessary to 
understand which films will be more successful than others at protecting the electronic. Using 
electrochemical impedance spectroscopy (EIS), the chemical stability of Al2O3, ZrO2, HfO2, and 
TiO2 were tested in three different simulated biological environments: phosphate buffer solution 
(PBS), simulated sweat, and simulated saliva. PBS is a simplified biological environment, 
mimicking physiological buffers naturally found in the human body. Simulated sweat (artificial 
perspiration) most closely resembles human eccrine perspiration. Simulated saliva (Fusayama/
Meyer artificial saliva) was chosen based on its primary use for testing biodegradability of dental 
metal alloys. With the results of this study determined over a 500-hour period, new methods of 
protecting flexible, biological implants will be established.  
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METHODS and MATERIALS 
Sample Preparation 
ALD films were deposited onto gold coated electrodes using plasma enhanced atomic 
layer deposition (PEALD) system (Cambridge Nanotech, Fiji) at 100°C. For PEALD deposition, 
t r ime thy l a luminum (TMA) , t e t r ak i s (d ime thy lamido) ha fn ium (TDMAH) , 
tetrakis(dimethylamido) titanium (TDMAT), and tetrakis(dimethylamido) zirconium (TDMAZ) 
were the precursors for the deposition of Al2O3, HfO2, TiO2 and ZrO2, respectively. Oxygen 
plasma was used for 20 seconds as an oxidizer with plasma power of 300 W. The thicknesses of 
ALD films were measured using Woollam M2000 ellipsometer by depositing them on silicon 
substrate. 
The solutions utilized in this experiment were PBS, simulated saliva, and sweat. PBS was 
obtained in powder form from Amresco and the PBS solution with strength of 1x was prepared 
by dissolving 9.88g of powder in 1L deionized water. Both the simulated sweat and simulated 
saliva solutions were provided by Pickering Laboratories, Inc. Simulated saliva (Fusayama/
Meyer Artificial Saliva) consisted of 97-100% deionized water, ≤  1.0% KCl, ≤  0.5% urea, ≤ 
0.1% NaCl, ≤ 0.1% sodium phosphate monobasic dehydrate, ≤ 0.1% calcium chloride dehydrate, 
and ≤  0.0005% sodium sulfide nonahydrate. Simulated sweat (Artificial Perspiration, DIN 
53160-2:2010/BS EN 1811:2011) consisted of 98-99% deionized water, ≤  1.0% NaCl, ≤  0.5% 
urea, and ≤ 0.5% lactic acid. 
Cytocompatibility 
MTT crystal was purchased from biotium (Cat:30006). DMEM and calf serum were 
purchased from ATCC. The cytotoxicity evaluation of ALD materials was performed with (3-
(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) (MTT) assay. Coverslips coated 
with HfO2, Al2O3, ZrO2 and TiO2 were sterilized under UV for 30min and then carefully moved 
to 24 well plates. NIH-3T3 (passage 100) were seeded on top of the coated coverslips at density 
of 50,000/well in complete medium (DMEM with 10% calf serum). MTT assay were performed 
according to manufacturer’s protocol. 
Cell mediums were removed after culturing for 18h at 37˚C (5% CO2). MTT reagent was 
added to each well within the well plate according to manufacturer’s protocol. After 2h 
incubation, double volume of DMSO was added to each well and pipette up and down several 
times to dissolve the formazan salt. Upon mixture, the absorbance signal was measured on a 
plate reader (BioTek Synergy H4) at 570nm (signal) and 630nm (background). Normalized 
absorbance values were obtained by subtraction background absorbance (630nm) from signal 
absorbance (570nm). 
Corrosion Resistance 
Electrochemical impedance spectroscopy (EIS) measurements were performed using a 
Reference 600TM potentiostat from Gamry Instruments. Custom built electrochemical cells were 
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used for taking electrochemical impedance measurements. The schematic of the cell is shown in 
Figure 1. The electrical contacts were made from top of the electrode while solution the bottom 
half of the electrode. The area of the electrode submerged into the solution is 4.17 cm2. EIS 
measurements were conducted in phosphate buffer saline (PBS) solution, simulated saliva and 
sweat solutions by applying a frequency range from 10-1 to 105 Hz and an amplitude of 10 mV. 
The measurements were taken at regular intervals over a period of 500-hours. 
!  
Figure 1. EIS Setup 
Surface Characterization 
Chemical characterization of the ALD films were conducted with X-ray photoelectron 
spectroscopy (XPS) on a Thermo Scientific K-Alpha X-ray photoelectron spectrometer system 
with a monochromatic Al Kα X-ray source (hν = 1486.6 eV). The chemical state of the ALD 
materials was determined before and after exposure to the solutions for 500 hours. To 
compensate for charging effect, all the XPS spectra were shifted with respect to adventitious 
carbon (C1s) peak at 284.8 eV.  
RESULTS 
Cytocompatibility 
To test the cytocompatibility of ALD materials, a MTT based in vitro cytotoxicity study 
was performed with NIH-3T3 cells culturing on ALD coated slides for 18 hours. To compare 
each of the experimental groups (cells culturing on ALD coated slides) with control group (cells 
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culturing on plain tissue culture plates), Dunnett’s statistics test was performed with one-way 
ANOVA multiple comparison. No significant difference in cell viability was observed, as shown 
in Figure 2. 
!  
Figure 2. Normalized absorbance intensity of 570 nm wavelength through the control and ALD coated coverslips 
EIS Measurements 
1. ALD Films in PBS 
The bode plots of ALD films in PBS solution are shown in Figure 3. The inset in 
the figures represent phase change plots of first and last measurement for the respective 
materials. For ALD Al2O3, there is high impedance in low frequency regions as seen in 
the inset of Figure 3(a). Figure 3(b) shows the bode plots for ALD HfO2 in PBS solution. 
There is not significant difference in the initial and final impedance plots of the ALD 
HfO2 layer.  
Figure 3(c) shows the bode plots for ALD TiO2 in PBS solution. The plots 
demonstrate no significant change in impedance response of the sample with time. All the 
impedance plots appear to overlap indicating that there is no significant change in the 
material with time. Figure 3(d) shows the bode plots for ALD ZrO2 in PBS solution. The 
impedance response from the ALD ZrO2 material has changed with time, there is more 
widening between the impedance plots in the low frequency region. 
!  v
!  
Figure 3. EIS response in PBS solution for (a) Al2O3, (b) HfO2, (c) TiO2, and (d) ZrO2 over a time period of 500-
hours. Dotted line represents impedance response from bare electrode. Blue arrows point towards the direction of 
measured data. Insets in the figure represent phase response for first and last measurement. Red arrow point 
towards the appearance of second time constant in the phase plots. 
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Figure 4. XPS spectra of metallic elements. Color code: Black represents binding energy for native samples (before 
exposure) to biological solutions. Red, green and blue represent binding energy for samples in PBS, saliva and 
sweat after exposure for 500-hours, respectively. 
2. ALD Films in Saliva 
The bode plots for the ALD films in saliva solution are shown in Figure 5. The 
inset in the figures represent phase change plots of initial and last measurement for 
respective materials. For ALD Al2O3, there is high impedance in the low frequency 
region as seen in the Figure 5(a). After day 1, there is sudden change in the impedance 
response of the ALD Al2O3 material. Figure 5(b) shows the bode plots for ALD HfO2 in 
saliva solution. With exposure of the film to saliva solution, there is a change in 
impedance response.  
Figure 5(c) shows the bode plots for ALD TiO2 in saliva solution. The plots 
demonstrate a slight change in impedance response of the sample with time. When 
comparing the impedance response of the material over 500 hours, it is evident from the 
inset of Figure 5(c) that there is widening in impedance response on either side of ~5 Hz 
frequency. 
Figure 5(d) shows the bode plots for ALD ZrO2 in saliva solution. The impedance 
response from the ALD ZrO2 material has no noticeable change with time. From inset in 
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the Figure 5(d), it is evident that there is no significant change in the time constant for 
last measurement as compared to the initial measurement. 
  
Figure 5: EIS response in saliva solution for (a) Al2O3, (b) HfO2, (c) TiO2, and (d) ZrO2 over a time period of 500 
hours. Dotted line represents impedance response from bare electrode. Blue arrows point towards the direction of 
measured data. Insets in the figure represent phase response for first and last measurement. Red arrow point 
towards the appearance of second time constant in the phase plots. 
3. ALD Films in Sweat 
The bode plots of the ALD films in sweat solution are shown in Figure 6. For 
ALD Al2O3, similar to that of other two solutions, there is high impedance in low 
frequency region as shown in the Figure 6(a). Figure 6(b) shows the bode plots for ALD 
HfO2 in sweat solution.  
Figure 6(c) shows the bode plots for ALD TiO2 in sweat solution. With exposure 
of the material to sweat solution, the impedance response from the ALD material changes 
in the lower frequency region. Figure 6(d) shows the bode plots for ALD ZrO2 in sweat 
solution. With exposure of the ALD film to sweat solution, a continuous change in the 
impedance spectra was observed with time.  
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Figure 6: EIS response in sweat solution for (a) Al2O3, (b) HfO2, (c) TiO2, and (d) ZrO2 over a time period of 500 
hours. Dotted line represents impedance response from bare electrode. Blue arrows point towards the direction of 
measured data. Insets in the figure represent phase response for first and last measurement. Red arrow point 
towards the appearance of second time constant in the phase plots. 
DISCUSSION 
Cytocompatibility 
Due to the negligible difference in the cell viability observed for the 4 ALD materials, the 
metal-oxide coatings have no cytotoxicity effect. Therefore, all of the ALD coatings chosen for 
this study demonstrate cytocompatibility for use in devices exposed to biological environments.  
EIS 
1. ALD in PBS 
With prolonged exposure of ALD Al2O3 to the PBS solution, there is a continuous 
decrease in the impedance of the film in the lower frequency regime, approaching the 
impedance of the bare electrode, as shown in Figure 3(a). The minimum value was 
obtained on the 22nd measurement at 500 hours. Similar tendency was observed for phase 
shift as well. The phase response of the ALD Al2O3 shifted towards that of the bare 
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electrode on last day of measurement. This indicates that there is a continuous thinning of 
the ALD Al2O3 layer due to dissolution of the material into the PBS solution. The XPS 
data for ALD Al2O3 in PBS solution is shown in Figure 4(a). It is clear from the XPS data 
that the intensity of Al2p peak has reduced significantly and only traces of Al2O3 remain 
on the electrode surface. The peaks from the electrode material, i.e. Ti and Au (not 
shown), were clearly visible, conforming the removal of ALD Al2O3 from the electrode 
surface. 
With exposure of the ALD HfO2 film to saliva solution, there is a change in 
impedance response indicating degradation of the material as shown in the encircled 
region of Figure 3(b) with the widening in the gap between impedance plots in the low 
frequency region (below ~50 Hz). The widening in the impedance response at lower 
frequencies and appearance of an additional time constant indicates the formation of a 
new capacitive area in the sample, diverging from the initial, uniform film. However, 
after exposure to the PBS solution, degradation started in the material. The XPS data 
revealed that there is a peak shift in the binding energy of Hf4f indicating a chemical 
change in the ALD material, as shown in Figure 4. This is consistent with the results from 
EIS where there some change in the material was observed. While broadening in the low 
frequency region, the impedance data shift towards that of the bare electrode indicating 
that the newly formed region is thinner than other regions of ALD HfO2. This means that 
the degradation of the ALD HfO2 is not uniform as that of ALD Al2O3. Instead, localized 
degradation or thinning occurred in the HfO2 layer which could be the result of selective 
etching of the material near the defect sites. 
The phase plot of ALD TiO2 taken after 500 hours of exposure to PBS overlaps 
with the first measurement plot indicating that ALD TiO2 is stable in PBS solution. This 
is also supported by overlap in binding energy peaks for Ti2p before and after exposure 
to PBS for 500 hours, as shown in Figure 7.   
The formation of second region of thickness different from rest of the material in 
ALD ALD ZrO2 is supported by the appearance of second time constant in the phase 
response of ALD ZrO2 as shown in the Figure 3(d). This means that there is localized 
degradation of the material. XPS data revealed that there is a shift in binding energy for 
Zr3d peaks, as shown in Figure 3(d), resulting from change in chemical state of Zr in 
ALD ZrO2. 
2.  ALD in Saliva 
The impedance from the sample matches to that of the bare electrode indicating 
that ALD Al2O3 was completely removed from the substrate surface. As shown in the 
inset of Figure 5(a), the phase change plot for ALD Al2O3 after 500 hours overlaps to that 
of the electrode. The XPS spectra taken for this sample after 500 hours show that there is 
no trace of Al on substrate surface as shown in Figure 7(a). Only the peaks for Ti and Au 
from the electrode were obtained which is consistent with the observation from EIS data. 
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Thus, ALD Al2O3 got completely dissolved into the saliva solution within a day, such that 
no intermediate step could be detected. This means that ALD Al2O3 is highly unstable in 
saliva solution. 
When comparing the data taken over a period of 500 hours, it is evident that in the 
middle region of frequency (~100 Hz), the impedance plots overlap throughout the 
measurement period as shown in the Figure 5(b). However, there is a continuous 
widening in the gap between the impedance plots at lower frequency region. From the 
inset in the Figure 5(b), it is seen that there are two time constants as opposed to only one 
in case of first measurement. The XPS spectra taken for ALD HfO2 after 500 hours of 
exposure to saliva solution shows that there is a shift in peak of Hf4f towards lower 
binding energy. The shift towards a lower binding energy of the ALD HfO2 material 
means that HfO2 is not entirely stable, chemically, in the saliva solution. However, the 
rate of chemical degradation of the material is not as fast as that of ALD Al2O3. As 
indicated by the EIS and XPS data, ALD HfO2 gets dissolved into the solution resulting 
into the thinning of the ALD layer. However, non-uniform decrease in thickness of the 
material means that there is selective etching or removal of ALD HfO2. This could be the 
result of presence of highly vulnerable sites near the proximity of pinholes and other 
defects. 
The widening of the impedance response indicates the formation of two different 
regions in the sample which should have two different time constants. This is confirmed 
by the phase change plot in the inset of Figure 5(c) where there is appearance of two time 
constants. This could be the result of slow degradation of ALD TiO2 at some selective 
regions in saliva solution. XPS data reveals that there is an increase in binding energy of 
Ti on exposure to saliva indicating towards the chemical interaction between the ALD 
TiO2 and components of saliva solution. Thus, XPS data supports the conclusion from 
EIS data of having change in the state of TiO2 material. Since there is formation of two 
regions with different thicknesses, the decrease in thickness of the sample in certain 
regions could be due to the rapid degradation at highly vulnerable sites near the defects in 
the layer. 
The negligible change in impedance response for ALD ZrO2 in simulated saliva 
indicates that there is no apparent dissolution of ALD ZrO2 into the surrounding media. 
However, as per XPS data, there is a change in peak position for binding energy of Zr3d 
towards lower value indicating a change in chemical state of ZrO2 at the surface. But, 
consistent impedance response from the material throughout the experiment duration 
indicates that the newly formed material does not get dissolved into the saliva solution 
and thus get removed from the substrate surface. Thus, ALD ZrO2 can be considered to 
be a highly stable material in saliva solution. 
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3. ALD in Sweat 
With exposure of ALD Al2O3 to the sweat solution, a sudden change in impedance 
behavior of the film, similar to that in the saliva solution, was observed. The second 
impedance measurement, taken 48 hours after first measurement and exposure to 
simulated sweat, shifted significantly towards lower frequency overlapping with that of 
the bare electrode. The significant shift of the impedance plot towards the bare electrode 
means that there was complete removal of ALD Al2O3 within a day. From second 
measurement onwards, all the impedance data overlapped. XPS data, shown in Figure 7, 
shows that there is no trace of Al on the substrate which is consistent with the observation 
from EIS that the complete removal of ALD Al2O3 has taken place. Therefore, it can be 
concluded that ALD Al2O3 dissolved completely into the surrounding media within a day. 
After this, there was no material remaining on electrode surface for further dissolution 
and hence, no change in the impedance response from the sample was observed after day 
1 onwards. Thus, ALD Al2O3 is highly unstable in simulated sweat solution. 
With exposure of the film to sweat solution, the impedance response changes for 
ALD HfO2, as shown in Figure 6(b). When comparing the data taken over the period of 
500 hours, it is evident in the middle to low frequency regime (below ~100 Hz) that the 
impedance plots start to diverge greatly throughout the measurement period. The 
formation of a region in the ALD HfO2 sample which has different thickness than rest of 
the sample is supported by the presence of two time constants for the sample after 500 
hours as shown in the inset of the Figure 6(b). The thinning in the HfO2 layer could be 
the result of dissolution of material into the solution. XPS analysis of the surface after 
500 hours, as shown in Figure 7(b), revealed that there is a shift in binding energy for 
Hf4f, indicating a change in chemical state of the ALD material. This signifies possible 
dissolution of HfO2 into the solution as a result of chemical interaction with the 
surrounding species. Thus, HfO2 is not stable in sweat solution. 
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In Figure 6(c), widening in the gap between impedance plots can be observed 
with time in the region below the frequency of ~10 Hz, The widening gap between 
impedance plots for ALD TiO2 indicates the formation of a region with thickness 
different than rest of the material, similar to that of ALD HfO2. This is supported by the 
presence of second time constant in the inset of the Figure 6(c). As the impedance plot in 
low frequency region tends to shift towards that of the bare electrode, it can be concluded 
that there is thinning in the material thickness in some parts of the sample. The decrease 
in thickness of the sample could be due to the formation of defects and removal of 
material from the ALD layer. The XPS spectra, as shown in Figure 7, shows that there is 
a peak shift in the binding energy of Ti2p peaks. This implies that there is chemical 
interaction between ALD TiO2 and the surrounding species which could have resulted in 
dissolution of the material into the solution, leading to thinning of the ALD layer. As per 
impedance data, the change in thickness of TiO2 is not uniform throughout the sample. 
This means that the rate of decrease in thickness of the TiO2 layer is higher at sites in the 
proximity of defects. Since the broadening in the impedance peak in case of TiO2 was 
smaller than that of HfO2, it can be concluded that TiO2 is more stable in sweat. 
From Figure 6(d), it is evident that there is widening in the gap between the 
impedance plots for the frequencies below ~10 Hz. The widening between impedance 
measurements at low frequencies for ALD ZrO2 indicates the formation of a region which 
has thickness different than rest of the sample, similar to that of HfO2 and TiO2. The 
existence of two regions with different thicknesses is supported by the presence of second 
time constant for impedance data on the 22nd measurement at 500 hours. Since the 
impedance response of the ALD material in lower frequency regions tends to approach 
that of the bare electrode, it can be concluded that the new region formed has a thickness 
smaller than the initial thickness of the sample. The XPS data revealed that there is a 
change in peak position for the binding energy of the Zr3d on exposure to sweat solution 
for 500 hours. This means that there is some chemical interaction between ALD ZrO2 and 
the surrounding solution leading to dissolution of the material into the solution. This 
results in thinning of the ALD layer as indicated by the impedance data. As the decrease 
in thickness is not uniform throughout the ALD layer, localized thinning in selective 
regions of the sample could be suspected. This localized thinning in the ALD layer can be 
associated to the defects in the film which make the areas of the film in their proximity to 
be highly vulnerable to attack from the solution. Although, ZrO2 might have shown some 
degradation in sweat solution, it is found to be more stable than the other three ALD 
materials under consideration for this study. 
CONCLUSION 
!  xiii
 A biocompatible, protective barrier for electronic medical implants may improve the 
lifetime of the device. Through the experiment, all four metal oxides were proven to be 
cytocompatible through MTT cell proliferation assay. Of the four metal oxides, ALD Al2O3 
proved to be an unstable choice in all three solutions for long-term protection of a biological 
implant. In both simulated sweat and saliva, there was no Al2O3 remaining after 24 hours of 
exposure while in PBS there was a constant degradation of the barrier until no Al2O3 is 
remaining. The other metal oxides, TiO2, ZrO2, and HfO2, demonstrated varying levels of 
protection while submerged in three different simulations of the human body. ALD TiO2 
demonstrated the highest success at long-term protection in PBS while ALD ZrO2 was the most 
stable in simulated sweat and saliva. Using ALD ZrO2 and TiO2, the viability of the barrier 
coatings will be demonstrated on a flexible silver electrode. Through the viability study, the 
applicability of the ALD metal oxides will establish their ability to sustain the electronics’ 
performance. The ALD metal oxide protective barriers are an opportunity to maintain the 
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